Atlas Trials

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Clinical trial NCT06056362 · RECRUITING

Trial details

NCT number
NCT06056362
Sponsor
Peking Union Medical College Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2023-03-23
Primary completion
2025-03-27
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.